Avanos Medical, Inc. (AVNS) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is neutral — 1 Buy, 6 Hold, 1 Sell.
The consensus price target is $23.00 (low: $20.00, high: $26.00), representing a downside of 6.6% from the current price $24.63.
Analysts estimate Earnings Per Share (EPS) of $1.33 and revenue of $0.69B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-8.53 vs est $1.33 (missed -743.8%). 2025: actual $-1.46 vs est $0.90 (missed -262.2%). Analyst accuracy: 0%.
AVNS Stock — 12-Month Price Forecast
$23.00
▼ -6.62% Downside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Avanos Medical, Inc., the average price target is $23.00, with a high forecast of $26.00, and a low forecast of $20.00.
The average price target represents a -6.62% change from the last price of $24.63.
Highest Price Target
$26.00
Average Price Target
$23.00
Lowest Price Target
$20.00
AVNS Analyst Ratings
Hold
Based on 8 analysts giving stock ratings to Avanos Medical, Inc. in the past 3 months
EPS Estimates — AVNS
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$8.53
vs Est $1.33
▼ 115.5% off
2025
Actual –$1.46
vs Est $0.90
▼ 161.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect the company to turn profitable.
Revenue Estimates — AVNS
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.688B
vs Est $0.685B
▲ 0.3% off
2025
Actual $0.701B
vs Est $0.695B
▲ 0.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
